NEWS: APRIL 2005

-04/29/2005-

GlaxoSmithKline to acquire Corixa Corp. for $300 million cash. To read article click here.

Telik Inc. will report 1Q/2005 financial results on Thursday, May 5, 2005. To read article click here.

FDA approves Amylin Pharmaceuticals Inc. and Eli Lilly's BYETTA™ (exenatide) injection for Type 2 diabetes. To read article click here.

A.P. Pharma initiates Phase II clinical trials of APF530 for cancer. To read article click here.

Antisense Pharma GmbH to begin Phase IIb clinicla trials of its TGF-beta2 antisense inhibitor AP 12009 for malignant brain tumor treatment. To read article click here.

-04/28/2005-

Press Release: The CELLspin from INTEGRA Biosciences is a compact system with remote control for spinning cell culture volumes from 100 to 1000 ml at up to 5 rpm. Two CELLspin systems fit comfortably inside a standard size incubator. To read press release click here.

Seattle Genetics Inc. and MedImmune Inc. form antibody-drug collaboration. To read article click here.

MIGENIX Inc. to inititate Phase I clinical trials of MX-4509 for neurodegenerative diseases. To read article click here.

Advanced Life Sciences goes public. To read article click here.

Bayer HealthCare AG spins-off Actimis Pharmaceuticals. To read article click here.

Life Medical Sciences Inc. changes its name to SyntheMed Inc. To read article click here.

-04/27/2005-

Press Release: Guava Technologies, Inc., a privately held biotechnology and medical device company, and AHF Global Immunity, an international initiative of AIDS Healthcare Foundation, the largest specialised provider of HIV/AIDS medical care in the United States, today announced a partnership aimed at increasing access in resource-limited nations to AIDS diagnosis and treatment monitoring. To read press release click here.

Vical Incorporated to take its vaccine against cytomegalovirus (CMV) to Phase II clinical trials. To read article click here.

Beckman Coulter Inc. to acquire Agencourt Bioscience Corporation. To read article click here.

ActiveSight and Lexicon Pharmaceuticals sign protein crystallography agreement. To read article click here.

-04/26/2005-

Gilead Sciences' HIV pill fails. To read article click here.

OncoGenex Technologies Inc. in-licenses heat shock protein 27 (Hsp27) inhibitors from The University of British Columbia. To read article click here.

Cell Genesys Inc. begins Phase I clinical trials of CG0070 for multiple cancers. To read article click here.

Amgen Inc. and Abgenix Inc. begin Phase III clinical trials of experimental fully human monoclonal Panitumumab for the treatment of metastatic colorectal cancer. To read article click here.

Insmed Inc. initiates Phase II clinical trials of SomatoKine® for Type A Extreme Insulin Resistance treatment. To read article click here.

-04/25/2005-

Press Release: Porvair Sciences Ltd., specialists in microplate technologies, have introduced a new range of adhesive and thermal sealing films and foils. To read press release click here.

Press Release: The CE440 Elemental Analyser from Exeter Analytical sets a new standard for high productivity and maximised confidence in your CHN/O/S analysis results. To read press release click here.

Exelixis Inc. files IND to the FDA for its VEGF, KIT and PDGF receptor tyrosine kinase inhibitor XL820. To read article click here.

-04/22/2005-

Press Release: GSK extends agreement with Peakdale for discovery research. To read press release click here.

Telik Inc. and the Mount Sinai School of Medicine form drug discovery cancer collaboration using Telik's proprietary TRAP technology. To read article click here.

-04/21/2005-

Press Release: ESA Inc. has chosen HPLC 2005 in Stockholm (26th - 30th June) for the European launch of its Pittcon Silver Award winning CORONA Charged Aerosol Detector, a new 'Universal' HPLC detector. To read press release click here.

Shire Pharmaceuticals to buy Transkaryotic Therapies Inc. for $1.6 billion. To read article click here.

Isis Pharmaceuticals Inc.'s second-generation antisense drugs selectively and effectively inhibit tumor growth. To read article click here.

Guilford Pharmaceuticals Inc. restarts AQUAVAN® Injection (GPI 15715) program. To read article click here.

-04/20/2005-

Press Release: Available from Radleys Discovery Technologies (RDT) the GreenHouse Blowdown Evaporator sets a new standard for productive and safe evaporation of chemistry samples, HPLC fractions and microplates. To read press release click here.

FDA grants fast-track status to Ariad Pharmaceuticals Inc.'s mTOR inhibitor AP23573 for cancer treatment. To read article click here.

Peregrine Pharmaceuticals Inc.'s Tarvacin™ effective for imaging solid tumors. To read article click here.

-04/19/2005-

Press Release: Genevac, market leaders in solvent removal technology, have reported widespread positive feedback from the first wave of users of their HT-24 Evaporation Workstation. To read press release click here.

Corgentech Inc. cuts its workforce by 45 percent. To read article click here.

Shire Pharmaceuticals Group's EQUETRO™ for bipolar disorder is now available in the United States. To read article click here.

Jazz Pharmaceuticals Inc. to buy Orphan Medical Inc. for $122.6 million in cash. To read article click here.

Vical Incorporated initiates clinical trials of investigational vaccine against West Nile virus. To read article click here.

Compugen Ltd. and Novartis form collaboration for pilot systems biologycresearch project. To read article click here.

-04/18/2005-

The National Cancer Institute stops clinical trials of AstraZeneca's cancer drug Iressa for not increasing patients' survival. To read article click here.

CV Therapeutics Inc.'s Ranexa meets primary endpoint in the reduction of angina attacks. To read article click here.

-04/01/2005-

Accelrys Inc. to present at the Stephens Nanotechnology conference in Pasadena, CA, USA. To read article click here.

Sanofi Pasteur receives $97 million flue vaccine contract from the U.S. Department of Health. To read article click here.

Alkermes Inc. submits NDA application to the FDA for approval of Vivitrex to treat alcohol dependence. To read article click here.

Genentech Inc. submits IND application to the FDA for Curis Inc.'s for drug candidate to treat skin cancer. To read article click here.

Exelixis Inc., Bayer CropScience and GenOptera LLC terminate Ag research collaboration. To read article click here.

Cytos Biotechnology AG and Medarex Inc. expnad collaboration. To read article click here.